NYSE$CLVT
Clarivate Plc · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
Clarivate reported Q4 2025 revenue of $617.0M and returned to GAAP profitability.
Q4 revenue $617.0M (organic -1.2%); net income $3.1M ($0.00 EPS) vs large prior loss; adjusted EPS $0.20. Organic ACV +1.8%; recurring revenue 88% of mix. Strategic review of Life Sciences & Healthcare sale ongoing.
- Q4 revenue $617M.
- Organic ACV +1.8%.
- Adjusted EPS $0.20.
- Recurring mix 88%.
Headline financials
Revenue & EPS history
Clarivate · Revenue · Quarterly
$617M
Revenue by segment
Clarivate · $333M total across 2 segments · Q2 2021
- Subscription$244M—73.1%
- Transactional$89.8M—26.9%
Forward guidance
2026 organic ACV and recurring revenue growth expected despite divestiture-related reported revenue decline.
Tailwinds
- Value Creation Plan lifting FCF.
- Agentic AI in portfolio.
- Share repurchases (56M FY).
Headwinds
- Transactional revenue declining.
- Divestiture uncertainty.
- Organic revenue slightly negative.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
-1.1%
Avg return
Earnings day
-0.2%
Avg return
5 days after
+1.5%
Avg return
30 days after
41%
12 / 29 earnings
Positive
+38.7%
Q4 2025
Best reaction
-29.0%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +13.9% | +11.6% | +0.8% | |
| Q4 2025 | +38.7% | +36.9% | +44.0% | |
| Q3 2025 | -3.6% | -2.7% | +3.3% | |
| Q1 2025 | +17.3% | +20.3% | +18.4% | |
| Q4 2024 | -1.4% | -5.4% | -15.3% | |
| Q3 2024 | -29.0% | -30.3% | -13.2% | |
| Q2 2024 | -17.4% | -7.5% | +8.3% | |
| Q1 2024 | -10.2% | -10.5% | -18.1% | |
| Q4 2023 | -20.9% | -20.1% | -16.9% | |
| Q3 2023 | +1.8% | -2.8% | +18.9% | |
| Q2 2023 | -23.8% | -26.5% | -18.8% | |
| Q1 2023 | +6.5% | +5.7% | +10.8% | |
| Q4 2022 | +13.2% | +9.4% | -7.3% | |
| Q3 2022 | -7.4% | +6.6% | -9.0% | |
| Q2 2022 | -7.5% | -9.2% | -16.3% | |
| Q1 2022 | -3.0% | -2.0% | +0.3% | |
| Q4 2021 | +10.1% | +11.0% | +24.8% | |
| Q3 2021 | +5.7% | +6.4% | +4.4% | |
| Q2 2021 | -5.6% | -4.1% | +3.6% | |
| Q1 2021 | +4.5% | +5.3% | +12.3% | |
| Q4 2020 | -19.0% | -17.8% | -11.6% | |
| Q3 2020 | -7.2% | -3.0% | -8.4% | |
| Q2 2020 | -4.0% | +2.4% | +0.3% | |
| Q1 2020 | +8.5% | +4.9% | +1.4% | |
| Q4 2019 | -1.4% | +4.3% | -1.1% | |
| Q3 2019 | +6.3% | +4.9% | +6.1% | |
| Q2 2019 | +8.1% | +7.1% | +9.1% | |
| Q4 2018 | -5.0% | +1.0% | +1.8% | |
| Q1 2019 | -0.8% | -1.3% | +9.8% | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q4 2017 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro